(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-methylbut-2-enoate

CAS : 495-83-0

Ref. 3D-AAA49583

Informations sur le produit

• Nom: (8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-methylbut-2-enoate
• Synonymes: (1R,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2Z)-2-methylbut-2-enoate, 1α<span class="text-smallcaps">H</smallcap>,5α<smallcap>H</span>-Tropan-3β-ol, 2-methylcrotonate (ester), (E)-, 2-Butenoic acid, 2-methyl-, (3-exo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (2E)-, 2-Butenoic acid, 2-methyl-, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, [1α,3α(E),5α]-, 3β-Tigloyloxytropane, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2E)-2-methylbut-2-enoate, Tigloidin, Tigloidina, Tigloidina [INN-Spanish], Tigloidine [INN:BAN], Tigloidinum, Tigloidinum [INN-Latin], Tigloyl pseudotropine, Tiglylpseudotropine, Tiglyssin, Tigloidine, Tigloidine, 1αH,5αH-Tropan-3β-ol, 2-methylcrotonate (ester), (E)-

Description

The active ingredient in this product is (8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-methylbut-2-enoate, a molecule that blocks the action of histamine at the H1 receptor. It is used as an antisecretory and antihistamine drug for relief of peptic ulcers and gastritis, as well as for treatment of bronchial asthma and allergic rhinitis. The active ingredient binds to histamine receptors on the basolateral membrane of gastric parietal cells, thereby inhibiting acetylcholine release from cholinergic nerve terminals in the myenteric plexus. This leads to inhibition of acid secretion by these cells and decreased production of gastric acid. The compound also inhibits the release of inflammatory mediators from mast cells, which leads to decreased inflammation in the stomach lining and reduced symptoms such as heartburn and abdominal pain.END>

NAME

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 223.31 g/mol
• Formule: C₁₃H₂₁NO₂
• Degré de pureté: Min. 95%